K213938: Revolution Ascend (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K213938 (Revolution Ascend, cleared 2022-02-04 for Ge Healthcare Japan Corporation) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K213938
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK213938
Cleared Device Trade / Generic NameRevolution Ascend
FDA Applicant on FilingGe Healthcare Japan Corporation
FDA 3-Letter Product ClassificationProduct Code JAK
FDA Substantial Equivalence Decision Date2022-02-04
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for GE HealthCare across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Ge Healthcare Japan Corporation, compare peer devices under FDA Product Code JAK, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.